Corventis Mobile Cardiac Telemetry Company
Corventis is a rather quiet mobile cardiac telemetry company located in northern California, USA. Corventis has a remarkable track record for raising money for the development and market introduction of their advanced form of mobile cardiac telemetry device called the NUVANT. Corventis has recently made headlines with the rumored acquisition of their mobile cardiac telemetry technology by device giant Medtronic.
Corventis Competitive Advantage
Corventis has attained extraordinary resources for the development of the mobile cardiac telemetry device called the NUVANT. The NUVANT MCT device technology is (by far) the most competitive advantage in the mobile cardiac telemetry marketplace. The NUVANT MCT device is above and beyond in terms of technology as this device comes in the form of a wearble patch that communicates with a mobile (wireless) devices. Like other MCT devices, the NUVANT mobile cardiac telemety device automatically detects, and automatically transmits abnormal ECG behavior to the Corventis laboratory. Although Corventis has little market share, the wearable patient compliant design of their device is superior to others in the industry.
Corventis Accreditations
Corventis received FDA market clearance of their NUVANT mobile cardiac telemetry device back in 2009. Corventis is a medicare approved Independent Diagnostic Testing Facility (IDTF) located in San Jose, CA.
